MyBlueDotsOncology & CancerLung cancer trial reveals 40% drop in deaths using biomarker testing MyBlueDots6 months ago01 mins New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths. Go to Source Author: Post navigation Previous: Data-driven study reveals falling use of antiseizure drug in pregnancyNext: AI analysis reveals four long COVID patient subgroups and needs
Why we need to take concussion and chronic traumatic encephalopathy more seriously MyBlueDots13 hours ago 0
Foreign medical residents fill critical positions at US hospitals, but are running into visa issues MyBlueDots2 days ago 0